REGISTER for the 2022 Thought Leader EHTEL Symposium: “European Health Data Space: Putting plans into practice”

 

The European Health Data Space has been a political ambition of the European Commission for some 2-3 years. In May 2022, it was published as a European Commission proposal for a Regulation.

The 2022 EHTEL Symposium draws on the association’s latest year of work and experiences on our continued journey towards Imagining 2029. It is part of our drive, in relation to the health data space, to bring clarity and predictability around how the EHDS implementation will affect a wide series of stakeholder types.

 

What to expect?

The event concentrates on practicalities. Look out for key topics like:

  • The electronic health record challenges when making real world data available for both primary and secondary use;
  • mHealth to enable the right of citizens to have easy, no-cost access to their own health data which can be shared as they wish;
  • The building blocks needed to facilitate cooperation on the use and re-use of real world data;
  • The societal data culture, and interoperability governance, needed to make the data space work well.

Take a look at the Programme for the two afternoons.

The EHTEL Symposium is a yearly event that brings together members of the European eHealth community to reflect on the latest trends in digital health. The event reflects stakeholders’ active engagement in innovating and deploying digital health for the benefit of health care systems.

 

When?

On 28-29 November 2022, experience two afternoons of seven in-depth sessions, presentations, debates, and networking opportunities.

 

How to attend?

Register for any, or all, of the sessions of your choice. Participation is free.

We look forward to having you with us on 28-29 November 2022!

SAVE THE DATE – 24 October – Securing Equitable Patient Access to Advanced Therapies across Europe

24 October – Securing Equitable Patient Access to Advanced Therapies across Europe

 

Active Citizenship is delighted to invite you to the event “Securing Equitable Patient Access to Advanced Therapies across Europe”

that will be held on October 24th, 2022 from 16:00 to 18:00 CEST in room JAN 6Q1 at the European Parliament in Brussels.

To attend the conference, please register here (registration is mandatory)

Kindly hosted by the Member of the European Parliament Tomislav Sokol (EPP group), co-chair of the MEPs Interest Group “European Patients’ Rights and Cross-border Healthcare”, the initiative is organized by Active Citizenship Network, the EU branch of Cittadinanzattiva, with the aim of contributing to provide a multi-stakeholder vision for equitable patient access to ATMPs.

Together with European institutions, academia, healthcare professionals, citizen organizations & Patient Advocacy Groups (PAGs), the private sector and key stakeholders, we will discuss the disruptive aspects of ATMPs and pay attention to the opportunities and challenges of new advanced therapies, which are expected to increase significantly over the next decade: an encouraging but equally challenging scenario, considering the high costs and public budget constraints faced by several EU countries. Aspects that must be addressed today in order not to be unprepared tomorrow.

The starting point is that the traditional reimbursement and budgeting schemes are unable to amortize the value of ATMPs, whose costs and benefits are not aligned. These types of therapies need new and different payment and accounting methods, which take into account the high initial costs and the large and lasting benefits over time, both for the patients and for the national health systems. It is time for an institutional mindset change to classify ATMPs expenditure as an investment and not a cost.

How can European institutions facilitate this process? What decisions are taken at the level of each Member State to make these therapies accessible to the largest number of eligible patients? What role do PAGs play? On this occasion, the Call to Action “Advanced Therapies Medicinal Products revolution & the respect of the patients’ right to access to care”, so far endorsed by 37 PAGs, will be officially presented at European level.

The event is realized in the framework of the European activities organized by Cittadinanzattiva with the unconditional support of the #VITA – Value and Innovation of Advanced Therapies coalition, coordinated by the global law firm LS CUBE.

To know more:

If you have further questions, please don’t hesitate to contact brussels@activecitizenship.net.

We look forward to welcoming you to our event!

Advancing nurses’ expertise on antimicrobial resistance

Ber Oomen, executive director of the European Specialist Nurses Organisation spoke to Health Europa about the organisation’s AMR, vaccination and infection prevention focus group and why greater policy support for the nursing workforce is needed.

Earlier this year, the International Nurses Day highlighted the urgent need to invest in the nursing workforce, advocating ‘Nurses: a voice to lead – invest in nursing and respect rights to secure global health’ as its chosen theme. Nurses have faced unprecedented challenges in recent years, and while they have endeavoured to meet the ever-increasing demands of healthcare systems, staff shortages, overwhelming workloads, and a lack of protection for their wellbeing have threatened the resilience of the profession, putting both nurses and their patients at greater risk. Policy action is urgently needed to address the unmet needs, particularly in the face of future global health threats such as antimicrobial resistance (AMR).

Building resilient healthcare systems is of particular importance in the fight against antimicrobial resistance. Nurses are often working on the frontline, monitoring patients and endeavouring to treat – sometimes life-threatening – infections which means it is vital they are equipped with the right skills and knowledge, but also the resources to deliver the best possible care. With its aim of securing long-term strategies and policies to advance the professional development of nurses as well as health projects in Europe, the European Specialist Nurses Organisation (ESNO) created an AMR, vaccination and infection prevention focus group and launched a three-year programme to promote educational resources and develop a harmonised standard for antimicrobial resistance stewardship and infection prevention curricula. The group is due to meet in September this year in Brussels. To discuss the ESNO microbial focus group programme and its key objectives to future-proof nurses’ competencies on AMR, Health Europa spoke to the ESNO’s executive director, Ber Oomen.

How did the ESNO microbial focus group come to be formed and what are its key goals?

Firstly, the focus group has two key goals which are complementary to each other: quality assurance of health provision and care and securing the best professionals for the most relevant position. In 2017, a range of meetings took place in the European Parliament which called for greater focus on antimicrobial resistance, and concurrently, vaccination, infection prevention and sepsis. However, all of these topics were being addressed in silos with separately funded, long-term programmes. For each topic, the ESNO decided to initiate educational activities, but it soon became clear that these would not have the intended impact unless the material was integrated. Likewise, it was only when the COVID-19 pandemic struck that healthcare professionals began to take stock of the information we were providing and the importance of understanding the potential health threats associated with infections and antimicrobial resistance.

While creating the initial version of our educational guides on microbes and medication, vaccination, AMR, and infection prevention, we were contacted by some wonderful and dedicated healthcare professionals who we later met in Brussels. We subsequently created a committee under the ESNO, and this continues to grow. It is a collaborative approach whereby we bring key experts together to create educational material for the wider healthcare community.

Why is it important for the nursing workforce in particular to be fully trained in understanding optimal antibiotic use? What are the key barriers that can prevent nurses from engaging in stewardship programmes and promoting best practices for antibiotic use?

The complexity of systems requires resources, which we just do not have. Like many other healthcare professionals, nurses are working in high-pressured and often stressful environments, and need to be supported with continuous training and competence building. Continuous training and knowledge sharing are important when it comes to administering medication as well as monitoring patients’ conditions, but also for the use of digital tools. The increasing use of Artificial Intelligence (AI), algorithms and personalised medication, as mentioned in the European Pharmaceutical Strategy means nurses will be required to understand and use these systems accordingly to monitor therapeutics, for example.

We are already seeing new devices being used in clinics and on wards to support antimicrobial resistance mitigation, such as Rapid Microbes Detection and Testing equipment to shorten testing times for infection samples from days to hours. Where in the past, samples had to go to laboratories to be tested, specialist nurses are now trained to manage these systems on the ward in order to improve prescribing processes and find alternative interventions when appropriate.

Robust educational pathways are crucial to optimising patient monitoring and enable nurses to build their skill set in AMR and stewardship while giving them a greater sense of responsibility and autonomy.

How is the global shortage of nurses and other healthcare professionals impacting the management and mitigation of AMR?

The nursing workforce shortage impacts the overall health system, and the amount of time healthcare professionals can spend with patients. Similarly, the lack of nurses being recruited to replace those that have left the profession, means the current workforce carries an even greater burden. This fragmented system is detrimental to the quality-of-care nurses endeavour to provide.

When it comes to patient care, simple interactions such as holding a hand, eye contact and listening can make the greatest difference to someone’s experience in care, and their recovery. We should not underestimate the value of patient interaction, and the benefit it brings to those receiving care and the ones who are providing it.

Personal contact also creates an element of trust, which is important when providing medication and explaining any practicalities to the patient.

Today, medication systems are more innovative than ever but can also be more complex given the uptake in digital solutions. Similarly, the diversity of products– from injections and sprays to glass pill pots – only adds to this complexity.

What actions could national health regulatory bodies and policymakers take to better support the nursing workforce and their involvement in approaches to AMR?

Firstly, we need to encourage an open and transparent culture. With infections, the first and too often obvious instinct is medication – an infection killer and antimicrobial – and in some cases these are absolutely necessary such as in a case of acute blood sepsis. But overall, there are so many, and often under-explored interventions when dealing with infections, and equally not all infections are the same.

Robust evaluation methods, monitoring and selective interventions are needed, and all nurses should be equipped with the basic competencies to carry out these tasks effectively. Existing recommendations such as the ‘10 nurses’ rights’ on antibiotic administration and factors influencing their practices should be suitably acknowledged.

While we are encouraged to apply for European funding and use budgetary systems, it is incredibly difficult because of administrative quagmires and the time-consuming implications of programmes. We need flexibility and freedom in our activities; our long-term vision is that nurses are given more credibility than thus far experienced. Many members of the European Commission understand this and have shown interest in supporting our cause.

Today’s key challenge for policymakers and regulatory authorities is to reach a comprehensive level of AMR awareness and understand how the nursing workforce can be supported to actively manage this. The COVID pandemic was a wake-up call to the potential danger of infections and the need for robust, and long-term strategies to mitigate future health threats.

Click here for more information.

Antimicrobial Resistance can affect all of us, no matter if you are a patient or not

Author: Ilaria Galetti, Vice President GILS ODV – Gruppo Italiano per la Lotta alla Sclerodermia.

Milan, Spring 1996. I was studying at the University, in an ancient cloister, when I noticed the first sign of the disease that would be my unfriendly and undesired partner of my life: systemic sclerosis, also known as scleroderma. Systemic sclerosis is a rare, autoimmune, and very complex condition, that can affect the skin, lungs, heart, gastrointestinal tract, joints, and overall, the whole body. One medicine has been approved for its treatment, but only for lung fibrosis and nothing else.

Clinical practice guidelines recommend immunosuppressive therapies to lower the immune system, but no selective or personalised therapies are available. This means that the whole immune system is affected, exposing the body to many infections. The disease causes digital ulcers, very painful and often infected, that need to be treated with topic or systemic antibiotics. A swab should always be performed to use the right antibiotics.

Immunosuppressive therapies are still too generic, meaning that they inhibit the whole immune system, paving the way to several infections (mainly lung infections). This can be difficult to treat and can require hospitalisation. A careful evaluation of which antibiotics or specific treatments must be used, should always be performed, targeting the right bacteria, viruses, or fungi.

The last two and a half years have taught us many things regarding prevention that should become routine in our daily life. Prevention plays an extremely important role. Hand hygiene, the use of masks when meeting people with the flu, meeting people who are not perfectly healthy, and when going to the hospital for check-up visits or infusion therapies, should be a must for the so-called fragile patients and their families. The lower the risk of infections, the lower the need to use antibiotics.

Another important issue is the adherence to the prescribed therapy. In too many cases the antibiotic therapy is halted by the patient when symptoms and signs of the illness disappear. Prescribers and pharmacists should stress the importance of adhering to the therapy in order to get a full healing and prevent a relapse. On top of this, patients often spontaneously use the pills that remain in their stock, with a sort of self-prescription to cure “potential” infections diagnosed by themselves.

In my experience at national and European level I would encourage a programme on the correct use of antimicrobics in the wider community of connective tissue diseases. A few tips to prevent the spread of antimicrobial resistance:

  • Don’t take an antibiotic for a virus: antibiotics only work against bacteria; they are not useful to cure a simple flu.
  • Don’t save an antibiotic for the next time you get sick: you cannot know what kind of bacteria you have.
  • Take antibiotics exactly as prescribed. Don’t skip doses. The efficacy is not immediate, it requires 3 or 4 days or even more.
  • Never take an antibiotic prescribed for someone else. As above: you do not know the bacteria has infected you.

These recommendations can help save lives including your life and the lives of those close to you.

Delivering Value through Innovation in Diabetes Care Delivery

Delivering Value through Innovation in Diabetes Care Delivery

 

About 10% of adults live with diabetes in Europe. Despite advances in care, education, medication, tools and technologies, the diabetes prevalence continues to rise, more than one third of people living with diabetes (PWD) remain undiagnosed, and up to half the PwD do not achieve adequate blood glucose management. To highlight key innovative developments and ways in which the adoption of innovation can be promoted, IDF Europe is launching a new publication: Delivering Value through Innovation in Diabetes Care Delivery.

During the launch webinar of IDF Europe’s new publication, speakers from a variety of background will explore the innovative tools, technologies and approaches with the most potential to improve the quality of life and health outcomes of people living with diabetes; share their perspectives on the main challenges associated with the scaling up of these innovations; review examples where innovation has successfully been implemented and what the role of stakeholders in fostering adoption should be.

 The event will take place on 16 June, 13.00-14.30 CEST

 More information about the event and how to register: https://www.insulin100.eu/event-delivering-value-through-innovation-in-diabetes-care-delivery-16-06-2022/

Please let the HFE Secretariat know if you need any additional information.

EHMA to host executive workshop on value-based healthcare

EHMA to host executive workshop on value-based healthcare

On 10 May, from 14:00 to 18:00 CET, the European Health Management Association (EHMA) will be hosting an online workshop on value-based healthcare, ‘Everybody’s business: value-based healthcare’. This will be the last workshop in the series ‘The many avenues of health management’.

The workshop will dive deep into understanding what value-based healthcare is and how health authorities and industry can contribute to making it happen. Why should health systems and organisations drive the value-based revolution, and what should they do to make it a reality? From framing the agenda to steering the cultural shift, attendees will be made part of the journey toward value-based healthcare.

Agenda

14.00-15.30 SESSION 1 – The big picture: making your health system/organisation valuable

15.30-15.45 Coffee break

15.45-16.45 SESSION 2 – Value generation on the ‘shop floor’

16.45-17.00 Coffee break

17.00-18.00 SESSION 3 – How to implement the VBHC revolution: a practical approach

The workshop will be led by Prof Federico Lega, PhD, Full Professor of Health Administration at the Public Health Department at Milan University. Prof Lega will be joined by esteemed guest speakers who are experts in value-based healthcare.

To learn more about the workshop and register, please visit this link.

Register for the EHMA 2022 Annual Conference

Register for the EHMA 2022 Annual Conference

In collaboration with the Leuven Institute for Healthcare Policy, the European Health Management Association (EHMA) will be hosting its 27th Annual Conference on 15-17 June 2022 in Brussels, Belgium. The conference title ‘From people to systems: leadership for a sustainable future’ will explore challenges and solutions for creating sustainable health systems and ways health managers can lead towards them.

One of EHMA’s main areas of work has been maintaining a dialogue between researchers, policymakers, health managers and professionals, thereby facilitating evidence-based policy refinement and change. The EHMA 2022 Annual Conference is a unique occasion for health managers, researchers, and professionals to have their voice heard, connect with decision-makers, and collectively inform policymaking at the European level.

The conference is structured around four tracks that reflect the holistic practice of health management, and frame the lenses through which contemporary topics are analysed and discussed. The tracks are:

  • Governance and Leadership;
  • Management, Operations and Practice;
  • Finance and Economics; and
  • Policy and Regulations.

Five optional topics have been chosen to help steer the focus, they include: People-centred systems; Managing the digital transformation; Workforce of the future; Shaping sustainable systems, and; Improving healthcare access, delivery and outcomes.

You can register for the conference here.
You can view the conference programme and speakers here.

Webinar: Supporting ambitious Diabetes and CVD Roadmaps in the context of the ‘Healthier Together – EU NCD Initiative’

Webinar: Supporting ambitious Diabetes and CVD Roadmaps in the context of the ‘Healthier Together – EU NCD Initiative’

By Alina Chebes, International Diabetes Federation European Region

Ten years after a landmark European Parliament Motion for a Resolution on Diabetes, MEPs Mobilising for Diabetes’ co-chairs, MEPs Sirpa Pietikäinen and Christel Schaldemose, with support from the MEP Heart Group, invite you to a webinar on May 12 at 8.00-9.00 to explore the progress achieved on tackling diabetes and CVD in the last decade and how an ambitious ‘Healthier Together – EU Non-Communicable Diseases (NCDs) Initiative’ can help achieve the many Resolution’s objectives that are still outstanding..

The Healthier Together Initiative was launched by the European Commission in December 2021. It aims to help Member States reduce the burden of major NCDs such as diabetes. Cardiovascular disease, for which diabetes is a key risk factor and which is also its leading cause of mortality, is also included in the initiative. A consensus document, described as a “toolkit to guide and coordinate action on NCDs” will be published by the Commission in June.

This initiative, which will be largely financed as part of the EU4Health programme, represents a major shift for the EC, which, until recently, had indicated that it would not support any disease-specific approaches other than cancer. The new vision is a unique opportunity to improve not only the prevention of diabetes and CVD but also the treatment, health outcomes and quality of life of the 32 million adults living with diabetes in the European Union.

Provisional Agenda:

Opening remarks

  • MEP Christel Schaldemose, MMD Co-Chair

Presentations

  • Status and the way forward for the EU NCD Initiative – Artur Furtado, Deputy Head of Unit, DG SANTE, European Commission
  • Improving diabetes care and quality of life: Priorities of the diabetes community (Joao-Filipe Raposo, Clinical Director at APDP – Diabetes Portugal and President of the Portuguese Society of Diabetology)
  • Improving CVD care and quality of life: Priorities of the CVD community (Martin Halle, President, Preventive Cardiology Association, European Society of Cardiology)

Panel discussion

  • Artur Furtado, Deputy Head of Unit, DG SANTE, European Commission
  • MEP Sirpa Pietikäinen, MMD Co-Chair
  • Charmaine Griffiths, President, European Heart Network
  • Chantal Mathieu, President, European Diabetes Forum
  • Niti Pall, Chair, International Diabetes Federation Europe

Closing remarks

  • MEP Sirpa Pietikäinen, MMD Co-Chair

The discussion will be moderated by Cajsa Linberg, IDF Europe Advisor.

You can register for the event here.

6 weeks to go until IPIC 5th Edition!

6 weeks to go until IPIC 5th Edition!

By Johan Prevot, International Patient Organisation for Primary Immunodeficiencies

IPOPI extends a warm invitation for all those wishing to participate in the next in-person International Primary Immunodeficiencies Congress – IPIC 5th Edition 27-29 April 2022 held in Vilamoura, Portugal.

Resume travel and meet up with world-renowned speakers and experts in the field, in addition to many other colleagues and stakeholders with an interest in PID/IEI.

Join hundreds of colleagues already registered: register here.

See the video of the conference here.

Screen4Rare & upcoming INSD 2022!

Screen4Rare & upcoming INSD 2022!

By Johan Prevot, International Patient Organisation for Primary Immunodeficiencies

International Patient Organisation for Primary Immunodeficiencies (IPOPI), International Society for Neonatal Screening (ISNS) and European Society for Immunodeficiencies (ESID) are proud to announce the new Screen4Rare website! Screen4Rare (S4R) is a multi-stakeholder platform aiming to exchange knowledge and best practices on newborn screening (NBS) for rare diseases.

S4R advocates the importance of NBS as a key element to access to care. The group’s ultimate objective is, through policy engagement, to work towards ensuring that all babies can have equitable access to newborn screening; a life-saving tool for conditions such as severe combined immunodeficiency (SCID).

S4R seeks to promote ‘The development of appropriate, well-organised and equitable newborn screening offered on a voluntary and informed basis to families to help identify well-defined treatable conditions where it is clear that their early asymptomatic detection and treatment during childhood results in significantly improved outcome.’

Learn more about the initiative’s goals and mission, recent NBS publications as well as upcoming events at www.screen4rare.org

Coming soon:

Exactly 4 months following the recent Rare Disease Day, Screen4Rare will celebrate International Neonatal Screening Day (INSD) on 28 June.

INSD aims to help raise awareness about the value of neonatal screening and encourage collaboration as a way of improving existing screening programmes and to take advantage of the latest scientific developments.

Stay tuned for upcoming details about the 2022 campaign.

 

2nd COTEC-ENOTHE Congress Free Workshops

A series of OT-Europe Workshops have been held in the run-up to the 2nd COTEC-ENOTHE Congress being held online between the 15-18 September 2021. The workshops are free of charge to delegates who have registered to the Congress. The themes of the workshops are very relevant to the overarching theme of the Congress – resilience – and reflect the contemporary ‘state of the art’ expertise in Occupational Therapy research, education and practice. The workshop themes are:

Interdisciplinary delirium – aiming to raise awareness about delirium among OTs and to build a basis for an OT network dealing with delirium

E-health – while e-health provides health care and rehabilitation contexts with new opportunities, alternatives and potentials for the benefit of occupational therapy and the society at large, there are also a number of critical issues to be considered, such as ethics, barries, e-health literacy, professional requirements and competencies

Health literacy – investing in health literacy has proven to strenghten individuals’ and organisations’ resilience. In this workshop OTs will discuss how occupational therapy contributes to health literacy on different levels.

School-based Occupational Therapy – discussions about the different ways occupational therapists are developing school-based interventions and about the curriculum guidelines that have been developed for OT students.

Displaced persons – understanding how to be responsive to the challenges of forced migration is critical for humanity. There is a growing interest for the potential for occupational therapists to engage in work with displaced persons.

If the themes of the workshops raise questions or ideas of potential collaboration, please contact info@oteurope.eu

Survey on RSV-associated burden and disruption to healthcare system

Fill out the survey on RSV-associated burden and disruption to healthcare system for a chance to win an Apple watch

By Tina Hadzig, European Health Management Association

The European Health Management Association (EHMA) is currently working on the production of a white paper providing evidence-based policy insights into the management and prevention of the respiratory syncytial virus (RSV) infection in Europe. EHMA is reaching out to healthcare providers in Europe to survey their views on the RSV-associated burden and disruption to the healthcare system.

For this purpose, four structured questionnaires (maximum 20 minutes) have been designed, addressing each of the care settings utilised by pediatric RSV patients:

Healthcare providers are asked to share their views on the system performance and pressures in the peak RSV season, and the actions required to mitigate the effects of RSV-associated health system disruption. The survey respondents can choose to have their name entered into a draw to win an Apple watch.

The information gathered will be published in a white paper providing evidence-based policy insights into the management and prevention of RSV infection in Europe, and assist decision-makers, health managers and other stakeholders take a long-term preventive approach for the future.

You can learn more here.

ESA Annual Meeting, September 9 – Register Now!

ESA Annual Meeting 2021
September 9th, 2021 | 14:00 – 16:50 CET

We are excited to invite you to the 4th ESA annual meeting! Join us on Thursday September 9, 2021 for this free event that will be held completely online. It will provide an opportunity to hear from policy makers, experts, and patients about how sepsis can fit into the European health agenda and what are the solutions to the lack of awareness and knowledge about sepsis.

SEPSIS CONTINUES TO COST LIVES

Despite some advances in some European countries, the limited attention offered to sepsis continues to undermine the efforts to improve its prevention, recognition, and management – and is costing lives. As described in a recent publication by the Global Sepsis Alliance and other scientific societies, most patients admitted in the ICU with COVID-19 progress into viral sepsis, making of sepsis the main cause of death in this pandemic. Health systems that are resilient against sepsis and severe infection will be resilient against future such pandemics.

Countries and regions have started taking encouraging actions, but this is not enough. We need to engage with more stakeholders to ensure that sepsis becomes a priority in the public health agenda for all countries across the whole European Union and continent.

Join the discussion on 9 September with representatives from WHO, European Parliament, Commission, Council, ECDC, renowned experts and patient groups.

Please find the programme of the event here.

EHMA to host its Annual Conference from 15 to 17 September

The European Health Management Association (EHMA) is delighted to host its Annual Conference under the theme ‘Health Management: managing the present and shaping the future’ on 15-17  September 2021.

This year, the Conference will take place digitally through the lens of Lisbon, Portugal and is organised in collaboration with the Associação Portuguesa de Administradores Hospitalares (APAH) and its academic partners, the Escola Nacional de Saúde Pública and the Universidade Nova: Nova School of Business and Economics.

Over the last year, health systems across Europe have encountered the most difficult times for a generation. Health services buckled under the strain of COVID-19, confronting enormous challenges around hospital capacity and workforce planning during a pandemic. As managers are pondering whether there will be a return to a ‘new normal’, important questions will be asked about how to increase the resilience and readiness of health systems whilst also providing high-quality routine care catching up on the backlog of many months of missed operations. Health management will be at the centre of providing solutions for these unprecedented difficulties. Bringing practitioners, researchers and academics together to share solutions has never been more important than today.

The EHMA Annual Conference is widely considered the preeminent place to share experiences, skills and competencies in the field of health management. With a strong focus on innovative practices in governing, planning and delivering services, the EHMA 2021 Annual Conference will be the perfect location to get in touch with your European and international colleagues discussing the latest developments in governance and leadership, digital transformation, integrated care, and creating sustainable person-centred services.

» View the full programme of the EHMA 2021 Annual Conference

» Register for the EHMA 2021 Annual Conference*

*You can benefit from a discounted registration fee until Monday, 6 September 2021.

Connecting the Dots: a new film series on medical technologies

Connecting the Dots: a new film series on medical technologies

By Tanja Valentin, Medtech Europe 

Connecting the Dots is an inspiring online video series, that explores the ways medical technologies – medical devices and diagnostics – are meeting healthcare challenges, from diagnosis to cure.

Connecting the Dots, produced by BBC StoryWorks for MedTech Europe and MedTech Europe members, highlights some of the most pioneering devices, diagnostic solutions and services that are improving outcomes for patients and transforming entire systems of care. The series showcases the work of the innovators, healthcare professionals and organisations fuelling progress by telling stories about the people at the heart of these developments.

Serge Bernasconi, CEO, MedTech Europe, said: “We are excited about the launch of this series produced by BBC StoryWorks. Tens of thousands of medical technology companies, many of them being SMEs, are working relentlessly day-by-day to provide life-saving innovations to patients, to make healthcare systems more efficient and more resilient. It is a great recognition for all of them to bring their work closer to the public. I am very pleased to have a large variety of our industry’s innovations represented, and common ambition reflected in this series.”

Please take some time to explore and learn about the medical technology sector by exploring our new series. Watch the series.

Living in COVID Times: Experiences from People living with Diabetes

Living in COVID Times: Experiences from People living with Diabetes

By Elizabeth Dupont, International Diabetes Federation Europe 

To better understand the experience of living with diabetes during the pandemic and the overall impact this had on their mental health, self-management and care, identify gaps in healthcare provision across Europe as well as good practices developed during the crisis, IDF Europe conducted a survey on the impact COVID-19 had on people with diabetes, based on their perceptions and experiences.

Between August and October of 2020, IDF Europe conducted a survey to gather perspectives from people with diabetes on their lives during the pandemic. The survey recorded responses from 3,480 people living with diabetes in 32 European countries. One of the key findings of the report revealed that the pandemic had a severe impact on the mental health of people living with diabetes, with over 50% of respondents reporting a deterioration in their mental health and over 40% indicating feeling very or extremely more anxious during this period.

The report also highlights many geographical inequalities in access to diabetes care across Europe. Difficulties in access, as well as financial worries, were especially marked in central and eastern European countries as well as in the south of Europe.

Download the report to read more about the findings and also IDF Europe’s recommendations for restructuring health systems post-pandemic here.